TBT Pharma, Inc. — Form D
TBT Pharma, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-05. The offering totals $2.0M, of which $700K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-01-05
- Form: D
- Accession: 0001838968-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $700K
- Remaining: $1.3M
- Minimum investment: $25K
- Investors: 4
- Date of first sale: 2020-12-23
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-385235
Issuer
- Name: TBT Pharma, Inc.
- CIK: 0001838968
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 708 HANOVER STREET, BALTIMORE, MD, 21230
- Phone: 9146725006
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Neil Cohen | Director | Dallas, TX |
| Steve Girgenti | Director | Bellmore, NY |
| Ian Tolfree | Director | Baltimore, MD |
| Ian Tolfree | Executive Officer | Baltimore, MD |
| Ian Tolfree | Promoter | Baltimore, MD |
More